CordenPharma Acquires AmbioPharm to Expand Global Peptide API Capacity

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1

Tags

CordenPharma

More Like This

PR Newswire associated0

CordenPharma Invests €900m in Transformational Peptide Platform Expansion in the USA & Europe

PR Newswire associated0

CordenPharma Expands Peptide Platform with more than 500 Million Euro Greenfield Facility Construction in the Basel Region of Switzerland

PR Newswire associated0

Cambrex Unveils $120 Million Investment to Expand API Manufacturing and Strengthen U.S. Drug Supply Resilience

PR Newswire associated0

CordenPharma and Viking Therapeutics Sign Long-Term Strategic Partnership for Integrated Supply of GLP-1 Peptides, Injectables and Oral Formulations

PR Newswire associated0

Cambrex Advances US and European Expansions

PR Newswire associated0

Cambrex Expands Peptide Manufacturing Capabilities in Waltham, Massachusetts

PR Newswire associated0

Ajinomoto Bio-Pharma Services and Olon S.p.A. Form Strategic Partnership to Advance Large-Scale Peptide and Protein Manufacturing

PR Newswire associated0

HAS Healthcare Advanced Synthesis SA acquires Cerbios-Pharma SA to create leading international Group in the CDMO sector, backed by 65 Equity Partners